Barcelona 2015 Programme Registration Glaucoma Day 2015 Exhibition Virtual Exhibition Satellite Meetings Hotel Booking Star Alliance

Take a look inside the London 2014 Congress


Then register to join us
in Barcelona!

Visco triple (combined viscocanalostomy, trabeculotomy and mitomycin-C) in congenital glaucoma

Search Abstracts by author or title
(results will display both Free Papers & Poster)

Session Details

Session Title: Glaucoma I

Session Date/Time: Monday 07/09/2015 | 08:00-10:30

Paper Time: 09:02

Venue: Room 10

First Author: : E.Ramadan SAUDI ARABIA

Co Author(s): :    A. Al Bahnasy                    

Abstract Details


To study and evaluate the outcomes of a new approach in managing congenital glaucoma visco trible (combined viscocanalostomy, trabeculotomy and mitomycin-C)


Magrabi Eye and Ear Center, Riyadh, KSA


In this study 11 eyes of seven infants (age range from 3dayes to 12 months only one age 6ys) 4 females ans 3 males . Viscocanalostomy is done with limbal based conjunctival flab after fashioning the superficial scleral flab Mitomycin-c was putted below the first flab and the bed then completing Viscocanalostomy as regular and injecting viscoelastic into schlem canal ostia then performing trabeculotomy leaving trabeculo-descemet window intact injecting viscoelastic in anterior chamber angle at site of trabeculotomy to tamponade it then closing the superficial scleral flab with 10/0 vicryl suture and closing the conjunctiva with 8/0 vicryl suture.


Mean preoperative IOP of 32.3 mm Hg (range, 25 to 44 mm Hg) decreased to a mean postoperative last visit IOP of 14 mm Hg (range, 11 to 18 mm Hg). Mean follow up period is 6Months-4Years.No intraoperative complication except for minimal controllable hyphema ,no hypotony or lost anterior chamber,no infection,follow up was 1 day,1week,2weeks monthly later on.only one case need surgical case need one medication


VISCO TRIBLE (COMBINED VISCOCANALOSTOMY,TRABECULOTOMY AND MITOMYCIN-C) is an effective and safe technique in managing congenital glaucoma with no intra or post operative complication achieving satisfactory IOP reduction and good lasting effect

Financial Interest:


Back to previous